MoonLake Immunotherapeutics MLTX Interest Expense
Discontinued — last reported Q1 '26
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's interest expense?
- MoonLake Immunotherapeutics (MLTX) reported interest expense of $2.27M in Q1 2026.
- How has MoonLake Immunotherapeutics's interest expense changed year-over-year?
- MoonLake Immunotherapeutics's interest expense increased by 12505.6% year-over-year, from $18K to $2.27M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.